临床决策支持和心脏代谢药物坚持:一项随机临床试验
Patrick J O'Connor1, Jacob L Haapala1, Steven P Dehmer1
1HealthPartners Institute, Bloomington, Minnesota.
JAMA network open
|January 9, 2025
概括
这项研究发现,临床决策支持和药剂师外展干预改善了血压 (BP) 药物坚持,但没有控制BP,胆固醇或A1c. 为了更好地管理心脏代谢风险因素,需要进一步修改.
科学领域:
- 心血管医学 心血管医学
- 内分泌学 在内分泌学.
- 医疗服务研究 医疗服务研究
背景情况:
- 药物坚持对于管理高血压,高脂血症和糖尿病至关重要.
- 需要有效的干预措施来改善患者对心脏代谢药物的坚持.
- 粘附不良会对血压 (BP),低密度脂蛋白胆固醇 (LDL-C) 和血红蛋白A1c (HbA1c) 的控制产生负面影响.
研究的目的:
- 评估一个干预措施,结合算法识别的低坚持,医生临床决策支持,和药剂师推广.
- 评估干预对心脏代谢药物坚持和控制BP,LDL-C和HbA1c的影响.
- 为了确定干预的成本效益.
主要方法:
- 这是一项涉及26家初级保健诊所的双臂患者随机临床试验.
- 参与者 (18-75岁) 血压,LDL-C或HbA1c的控制不足,药物坚持低 (覆盖日数<80%).
- 干预包括与电子健康记录相关的决策支持,以及符合条件的患者的药剂师电话联系.
主要成果:
- 干预改善了对血压药物的坚持 (AOR,1.29) 但不是他类药物或非胰岛素糖尿病药物.
- 没有观察到平均HbA1c,静脉血压或LDL-C总体水平的显著改善.
- 符合条件的干预患者与不符合条件的患者相比,HbA1c有所改善,但总体成本没有差异.
结论:
- 干预措施提高了对高血压药物的坚持,但没有改善整体心脏代谢控制.
- 目前的干预策略需要修改,以有效管理血压,LDL-C和HbA1c.
- 需要进一步的研究来优化对药物坚持和心脏代谢健康的干预措施.
相关概念视频
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
2.0K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.0K
01:15Diabetes: Management and Pharmacotherapy
233
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
233
01:16Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
01:22Heart Failure Drugs: β-Blockers
314
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
314
01:28Drug Therapy
37
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
37
01:25Antihypertensive Drugs: Direct Renin Inhibitors
484
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
484